St. Luke’s Medical Center - Global City marks a significant milestone for its cardiovascular services, having successfully completed over 300 ...
While many people fear a cancer diagnosis above all else, clinical data reveals that symptomatic aortic stenosis, a severe ...
On January 2, 2026, the US Food and Drug Administration (FDA) began accepting statements of interest for its Technology-Enabled Meaningful ...
Expands Global Footprint to 15 CountriesFORT MILL, S.C., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing ...
Johnson & Johnson now expects to bring in $100 billion in revenue in 2026. (Photo by Mario Tama/) Johnson & Johnson had ...
J&J has publicly declared its intention to be the world's top cancer drugmaker by 2030. It aims to generate $50 billion in ...
Johnson & Johnson ( JNJ) Q4 2025 Earnings Call January 21, 2026 8:30 AM EST Good morning, and welcome to Johnson & Johnson's Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] This ...
Anti-snoring device creator Zeus Sleep has been awarded £1.48 million of funding from the National Institute for Health and ...
SonoMotion, a venture-backed medical device company developing non-invasive solutions for kidney stones, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for ...
IBRX stock jumps 17% after FDA talks outline the path to resubmit Anktiva sBLA for papillary NMIBC, with additional analyses ...
On January 6, 2026, the U.S. Food and Drug Administration (“FDA”) published revised final guidance documents on Clinical Decision Support ...
Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be received upon the achievement of certain milestones Offer represents an approximate 85% premium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback